• About
    Company
    Reserch Recruitment
    Contact
    Careers
  • Platform
    Aging mechanism research
    AI Network pharmacology
    TURN A drug delivery
    Products evaluation and Clinical Research
  • Pipeline
  • Shop
  • News
  • Research
    Publications
    Celfavor™ NADH
News
      January 23, 2026

      Is NAD+ Oncogenic or Anticancer?

      Is There a Preference in NAD+'s "Energy Supply"?NAD+ is a core coenzyme for cellular energy metabolism, participating in critical physiological processes including mitochondrial ATP prod...

      Read More
      January 16, 2026

      NAD World 3.0: New Breakthrough in Aging Research

      Aging is an inevitable process for all, but scientists are steadily unraveling its underlying mysteries. In 2025, a landmark paper published by the Japanese Society of Anti-Aging Medicine in the journ...

      Read More
      January 09, 2026

      NAD⁺: Consumption Pathways, Endogenous Synthesis & Exogenous Supplementation

      In the microscopic world of cells, NAD⁺ (Nicotinamide Adenine Dinucleotide) plays an irreplaceable role as a core molecule in cellular energy metabolism, participating in critical physiological proces...

      Read More
  • January 04, 2026
    NAD+: A Key to Reversing the Fertility Clock? Insights from a New Review

    NAD+ (Nicotinamide Adenine Dinucleotide) is the essential "coenzyme" for over 400 cellular...

    Read More
  • December 26, 2025
    News Release: FDA Reinstates NMN’s Status as a Dietary Supplement, Ending Three-Year Regulatory Dispute

    Washington, D.C. – December 10, 2025 – A landmark announcement from the U.S. Food and Dr...

    Read More
  • December 19, 2025
    The Longevity Trio: Decoding the Interconnected Cycle of NMN, NAD+ and NADH

    At the cutting edge of anti-aging and health science, three molecular acronyms consistently take cen...

    Read More
  • December 12, 2025
    NADH Shows Remarkable Chemopreventive Potential Against Colorectal Cancer: Novel Mechanisms Uncovered

    Colorectal cancer (CRC) remains a severe global public health challenge. Despite advances in diagnos...

    Read More
  • December 05, 2025
    Transl Psychiatry: Early Life Stress + NAD+/SIRT1 Genetic Risk Drives Depression—A Cellular Energy Crisis

    For decades, depression has been unfairly dismissed as "overthinking" or "personal we...

    Read More
  • November 28, 2025
    Nature Aging: NAD⁺ Metabolic Checkpoint—A Key Target to Reverse Hematopoietic Stem Cell Aging

    With advancing age, the function of hematopoietic stem cells (HSCs)—the "seed cells"...

    Read More
Prev 123 Next
FOLLOW

Enter your email for exclusive offers, company news, more about our science, and more.

About
Company
Reserch Recruitment
Contact
Careers
Platform
Aging mechanism research
AI Network pharmacology
TURN A drug delivery
Products evaluation and Clinical Research
Pipeline
Shop
News
Research
Publications
Celfavor™ NADH
© 2026 CELFULL.com. All Rights Reserved. 5850 Coral Ridge DR,Coral Springs, FL 33076